Ulla Lepola

3.2k total citations
68 papers, 2.2k citations indexed

About

Ulla Lepola is a scholar working on Experimental and Cognitive Psychology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Ulla Lepola has authored 68 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Experimental and Cognitive Psychology, 25 papers in Pharmacology and 24 papers in Psychiatry and Mental health. Recurrent topics in Ulla Lepola's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (33 papers), Treatment of Major Depression (25 papers) and Mental Health Research Topics (15 papers). Ulla Lepola is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (33 papers), Treatment of Major Depression (25 papers) and Mental Health Research Topics (15 papers). Ulla Lepola collaborates with scholars based in Finland, Denmark and United Kingdom. Ulla Lepola's co-authors include Hannu Koponen, Esa Leìnonen, Henrik Loft, Elin Heldbo Reines, Alan Wade, Jyrki T. Kuikka, Kim Bergström, Jari Tiihonen, Paavo Riekkinen and Ranan Rimón and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

Ulla Lepola

67 papers receiving 2.1k citations

Peers

Countries citing papers authored by Ulla Lepola

Since Specialization

Citations

This map shows the geographic impact of Ulla Lepola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Lepola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Lepola more than expected).

Fields of papers citing papers by Ulla Lepola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Lepola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Lepola. The network helps show where Ulla Lepola may publish in the future.

Co-authorship network of co-authors of Ulla Lepola

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Lepola. A scholar is included among the top collaborators of Ulla Lepola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Lepola. Ulla Lepola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant 2013 ·European Neuropsychopharmacology ·Eduard Vieta, Michael E. Thase, Dieter Naber, (unknown), Elmārs Rancāns, Ulla Lepola, Bengt Olausson, Johan Szamosi, Ellis Wilson, David A. Hosford, G. C. Dunbar, Raj Tummala, Hans Eriksson	35
2	Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial 2010 ·Depression and Anxiety ·Michael R. Liebowitz, Raymond W. Lam, Ulla Lepola, Catherine Datto, Dennis Sweitzer, Hans Eriksson	69
3	Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial 2008 ·International Clinical Psychopharmacology ·P Boyer, Stuart Montgomery, Ulla Lepola, Jean‐Michel Germain, Claudine Brisard, (unknown), (unknown), Karen A. Tourian	108
4	Substituting Carbamazepine with Oxcarbazepine Increases Citalopram Levels. A Report on Two Cases 2007 ·Pharmacopsychiatry ·Esa Leìnonen, Ulla Lepola, Hannu Koponen	5
5	Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder 2004 ·International Clinical Psychopharmacology ·Ulla Lepola, Alan Wade, Henning Friis Andersen	76
6	Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double‐blind, placebo‐controlled, parallel‐group comparison with paroxetine 2004 ·Human Psychopharmacology Clinical and Experimental ·Christer Allgulander, Richard M. Mangano, Jun Zhang, Alv A. Dahl, Ulla Lepola, Ingemar Sjödin, Gérard Emilien	74
7	Sertraline Versus Imipramine Treatment of Comorbid Panic Disorder and Major Depressive Disorder 2003 ·The Journal of Clinical Psychiatry ·Ulla Lepola, Mihály Arató, Young Zhu, Carol D. Austin	30
8	Efficacy and Tolerability of Paroxetine for the Long-Term Treatment of Generalized Anxiety Disorder 2003 ·The Journal of Clinical Psychiatry ·Fabrizio Stocchi, (unknown), (unknown), Ulla Lepola, K. Hewett, (unknown), Malini Iyengar, (unknown)	91
9	A Controlled, Prospective, 1-Year Trial of Citalopram in the Treatment of Panic Disorder 1998 ·The Journal of Clinical Psychiatry ·Ulla Lepola, Alan Wade, Esa Leìnonen, Hannu Koponen, (unknown), Ingemar Sjödin, (unknown), (unknown), Heikki Lehto	82
10	Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis 1997 ·Molecular Psychiatry ·Jari Tiihonen, Jyrki T. Kuikka, Pirkko Räsänen, Ulla Lepola, Hannu Koponen, (unknown), (unknown), Pauli Vainio, Mervi Könönen, Kim Bergström, Meixiang Yu, (unknown), Karl E.O. Åkerman, Jari Karhu	117
11	Fluvoxamine increases the clozapine serum levels significantly 1996 ·European Neuropsychopharmacology ·Hannu Koponen, Esa Leìnonen, Ulla Lepola	42
12	Citalopram in the Treatment of Early-onset Panic Disorder and School Phobia 1996 ·Pharmacopsychiatry ·Ulla Lepola, Esa Leìnonen, Hannu Koponen	28
13	A naturalistic 6‐year follow‐up study of patients with panic disorder 1996 ·Acta Psychiatrica Scandinavica ·Ulla Lepola, Hannu Koponen, Esa Leìnonen	21
14	The Effect of Age and Concomitant Treatment with Other Psychoactive Drugs on Serum Concentrations of Citalopram Measured with a Nonenantioselective Method 1996 ·Therapeutic Drug Monitoring ·Esa Leìnonen, Ulla Lepola, Hannu Koponen, Ilpo Kinnunen	29
15	A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium 1994 ·European Archives of Psychiatry and Clinical Neuroscience ·Hannu Koponen, Ulla Lepola, Esa Leìnonen	13
16	Sleep in panic disorders 1994 ·Journal of Psychosomatic Research ·Ulla Lepola, Hannu Koponen, Esa Leìnonen	27
17	CSF corticotropin-releasing factor is not affected in panic disorder 1993 ·Biological Psychiatry ·Jukka Jolkkonen, Ulla Lepola, Garth Bissette, Charles B. Nemeroff, Paavo Riekkinen	36
18	Delirium During Fluoxetine Treatment: A Case Report 1993 ·Annals of Clinical Psychiatry ·Esa Leìnonen, Hannu Koponen, Ulla Lepola	12
19	Long‐term outcome after neuroleptic malignant syndrome 1991 ·Acta Psychiatrica Scandinavica ·Hannu Koponen, Eila Repo, Ulla Lepola	14
20	Long-Term Effects of Alprazolam and Imipramine on Cerebrospinal Fluid Monoamine Metabolites and Neuropeptides in Panic Disorder 1989 ·Neuropsychobiology ·Ulla Lepola, Jukka Jolkkonen, Ranan Rimón, P. Riekkinen	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact